rs699, AGT

N. diseases: 134
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE We conclude that heterozygous substitutions at the AGT M235T and REN A/G(I8-83) loci correlate significantly with ESRD in a north Indian population. 25660845 2015
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE Furthermore, there was no a markedly positive association between AGT M235T gene polymorphism and ESRD susceptibility in overall populations, Asians and Africans. 23065231 2013
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE This study was designed to evaluate the angiotensin-converting enzyme insertion/deletion (ACE-I/D), angiotensinogen (AGT) M235T, and angiotensin II receptor type 1 (ATR1) A1166C and type 2 (ATR2) C3123A gene polymorphisms as risk factors for progression to ESRD in patients with VUR.Methods. 19288324 2009
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE Two hundred and forty-six end-stage renal disease (ESRD) patients on peritoneal dialysis and 183 control subjects, all of Chinese origin, were genotyped for the ACE insertion/deletion (I/D) and the AGT M235T gene polymorphisms. 12675870 2003
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE We studied retrospectively the role of angiotensinogen (AGT) M235T, angiotensin converting enzyme (ACE) insertion/deletion (I/D), angiotensin II type 1 receptor (AT1R) A1166C, aldosterone syntase (CYP11B2) -344C/T and intron 2 W/C polymorphisms in conjunction with clinical and biochemical covariables on the rate of progression of renal insufficiency in a group of patients with ESRD of various etiologies. 12832734 2003
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE There were no differences in the prevalence of hypertension and the ages at the ESRD in relation to the AGT M235T and ATR A1166C polymorphisms. 12950120 2003
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE There was no association between age at onset of ESRD and either M235T or A1166C polymorphism. 11136175 2001
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group. 10916074 2000
Chronic kidney disease stage 5
CUI: C2316810
Disease: Chronic kidney disease stage 5
0.090 GeneticVariation BEFREE There was no interaction between age of onset of ESRF and either the angiotensinogen M235T allele or angiotensin 1 receptor A1166C polymorphism. 9291178 1997